Kozhikode’s Thalassemia Patients Remain Trapped in Costly Care Cycle
Patients in Kozhikode continue to purchase expensive leukocyte filter sets from a private firm, paying roughly ₹1,200 per unit, as public provision remains inadequate. The ongoing shortage highlights systemic gaps in regional health financing and supply chains.
In the coastal city of Kozhikode, families of thalassemia sufferers are forced to seek out private vendors for essential leukocyte filter sets, each costing around ₹1,200. Public hospitals, constrained by limited budgets and supply chain disruptions, have been unable to provide these critical consumables, leaving patients dependent on a single private supplier based in Ernakulam. Activists argue that the reliance on a monopolistic source inflates costs and places an undue financial burden on already vulnerable households.
The underlying tension reflects broader challenges within Kerala’s healthcare system, where high prevalence of genetic blood disorders collides with fiscal constraints and procurement inefficiencies. While the state boasts commendable health indicators, the lack of a coordinated procurement mechanism for specialized medical supplies has created a market vacuum that private entities exploit. Health officials have cited budgetary allocations and bureaucratic delays as obstacles to establishing a reliable public supply chain for these filters.
Consequences of the current arrangement are stark: families report diverting funds from education and nutrition to afford the filters, and some patients have missed essential transfusion sessions due to unaffordable costs. Advocacy groups have petitioned the state government for emergency funding and the establishment of a state‑run procurement hub to ensure affordable access. If addressed within the next year, the policy shift could alleviate financial strain and improve treatment adherence for thousands of thalassemia patients across the region.
Comments 0